R. Alten
R. Alten publishes mostly in Rheumatology, Hematology and Genetics, on topics such as Rheumatoid Arthritis Research and Therapies, Chronic Lymphocytic Leukemia Research and Autoimmune and Inflammatory Disorders Research.
- World rank
- #5,150,874 of 7,710,434 ranked researchers
- Rank in Germany
- #266,291 of 364,343
- Works
- 34
- Citations
- 251
- Citations per work
- 7.4
What does R. Alten research?
R. Alten's work is mostly in Medicine (61%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2161.3%
- Medicine2161.3%
- Everything else1133.3%
- Life Sciences25.4%
- 1Rheumatology29% of their works
- 2Hematology11% of their works
- 3Genetics10% of their works
- 4Pathology and Forensic Medicine8% of their works
- 5Immunology5% of their works
- 6Pediatrics, Perinatology and Child Health4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Chronic Lymphocytic Leukemia Research
- Autoimmune and Inflammatory Disorders Research
- Lymphoma Diagnosis and Treatment
- Pharmaceutical studies and practices
- Systemic Lupus Erythematosus Research
- Immunodeficiency and Autoimmune Disorders
- Chronic Myeloid Leukemia Treatments
Which keywords describe R. Alten's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Hemophagocytic Lymphohistiocytosis and Juvenile Idiopathic Arthritis.
- Primary Immunodeficiency
- Genetic Mutations
- Systemic Lupus Erythematosus
- Off-Label Drug Use
- Classification
- Juvenile Idiopathic Arthritis
- Genomic Aberrations
- Rituximab
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Chronic Lymphocytic Leukemia
- Hemophagocytic Lymphohistiocytosis
- Antiphospholipid Syndrome
- Lymphoma
- Pediatric Pharmacokinetics
- BCR-ABL
- Imatinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies242 topics
- Inflammation201 topic
- Rheumatoid Arthritis201 topic
- Rituximab122 topics
- Chronic Lymphocytic Leukemia81 topic
- Genomic Aberrations81 topic
- Hemophagocytic Lymphohistiocytosis71 topic
- Juvenile Idiopathic Arthritis71 topic
- Antiphospholipid Syndrome41 topic
- Classification41 topic
- Lymphoma41 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Systemic Lupus Erythematosus41 topic
- BCR-ABL31 topic
- Genetic Mutations31 topic
- Imatinib31 topic
- Primary Immunodeficiency31 topic
Where does R. Alten work?
R. Alten's main affiliation in the publication record is Schlosspark-Klinik, Germany.
How many publications and citations does R. Alten have?
OpenAlex counts 34 works and 251 citations for R. Alten, an h-index of 6, ranking #5,150,874 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. Alten. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.